[go: up one dir, main page]

WO1997018323A3 - Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes - Google Patents

Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes Download PDF

Info

Publication number
WO1997018323A3
WO1997018323A3 PCT/US1996/019337 US9619337W WO9718323A3 WO 1997018323 A3 WO1997018323 A3 WO 1997018323A3 US 9619337 W US9619337 W US 9619337W WO 9718323 A3 WO9718323 A3 WO 9718323A3
Authority
WO
WIPO (PCT)
Prior art keywords
pik
cycle checkpoint
cell cycle
phosphatidylinositol
assaying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/019337
Other languages
English (en)
Other versions
WO1997018323A2 (fr
Inventor
Merl F Hoekstra
Doug A Holtzman
Kathleen S Keegan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icos Corp
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SK1115-97A priority Critical patent/SK111597A3/sk
Application filed by Icos Corp filed Critical Icos Corp
Priority to IL12130696A priority patent/IL121306A0/xx
Priority to FI973005A priority patent/FI973005A7/fi
Priority to EP96945181A priority patent/EP0807169A3/fr
Priority to JP51918097A priority patent/JP2002515732A/ja
Priority to HU0002207A priority patent/HUP0002207A2/hu
Priority to MX9705466A priority patent/MX9705466A/es
Priority to AU14611/97A priority patent/AU1461197A/en
Publication of WO1997018323A2 publication Critical patent/WO1997018323A2/fr
Priority to NO973279A priority patent/NO973279L/no
Publication of WO1997018323A3 publication Critical patent/WO1997018323A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne d'une manière générale des gènes codant des protéines relatives à la phosphatidylinositol kinase (PIK) du point de contrôle du cycle cellulaire, ces protéines étant essentielles aux réponses de dommages de l'ADN dans les cellules. Ces kinases relatives à PIK sont nécessaires dans les chemins régulateurs qui arrêtent le cycle cellulaire suite à des dommages de l'ADN afin de permettre la réparation de l'ADN avant une mitose ou un début de réplication de l'ADN. Plus particulièrement, l'invention concerne une nouvelle kinase relative à PIK du point de contrôle du cycle des cellules humaines, MCCS1, et des séquences polynucléotidiques codant MCSS1. Des dosages permettant d'identifier des modulateurs de MCCS1 utiles par exemple en chimiothérapie et comme adjuvant de radiation sont également décrits dans l'invention. Celle-ci décrit également des dosages permettant d'identifier des modulateurs de la protéine relative à phosphatidylinositol kinase du point de contrôle du cycle cellulaire, lesquels ont reçu l'identification ATM.
PCT/US1996/019337 1995-11-16 1996-11-18 Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes Ceased WO1997018323A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU14611/97A AU1461197A (en) 1995-11-16 1996-11-18 Cell cycle checkpoint pik-related kinase materials and methods
IL12130696A IL121306A0 (en) 1995-11-16 1996-11-18 Cell cycle checkpoint pik-related kinase materials and methods
FI973005A FI973005A7 (fi) 1995-11-16 1996-11-18 Solusyklin kontrollikohdan PIK-sukuisia kinaasimateriaaleja ja menetel miä
EP96945181A EP0807169A3 (fr) 1995-11-16 1996-11-18 Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes
JP51918097A JP2002515732A (ja) 1995-11-16 1996-11-18 細胞周期チェックポイントｐｉｋ関連キナーゼ物質及び方法
SK1115-97A SK111597A3 (en) 1995-11-16 1996-11-18 Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity
MX9705466A MX9705466A (es) 1995-11-16 1996-11-18 Materiales y metodos de quinasa relacionada con fosfatidilinositolquinasa de punto de control del ciclo celular.
HU0002207A HUP0002207A2 (hu) 1996-10-21 1996-11-18 A sejtciklus szabályozási pont PIK-kel rokon kínázai és eljárás előállításukra
NO973279A NO973279L (no) 1995-11-16 1997-07-15 PIK-beslektede kinasematerialer og fremgangsmåter for cellesykluskontrollpunkt

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US55866695A 1995-11-16 1995-11-16
US73129696A 1996-02-27 1996-02-27
US72530496A 1996-10-21 1996-10-21
US08/558,666 1996-10-21
US08/007,312 1996-10-21
US08/725,304 1996-10-21

Publications (2)

Publication Number Publication Date
WO1997018323A2 WO1997018323A2 (fr) 1997-05-22
WO1997018323A3 true WO1997018323A3 (fr) 1997-10-09

Family

ID=27415779

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/019337 Ceased WO1997018323A2 (fr) 1995-11-16 1996-11-18 Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes

Country Status (6)

Country Link
CN (1) CN1199420A (fr)
AU (1) AU1461197A (fr)
IL (1) IL121306A0 (fr)
NO (1) NO973279L (fr)
PL (1) PL322876A1 (fr)
WO (1) WO1997018323A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
GB9518220D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
AU8400398A (en) * 1997-07-11 1999-02-08 Trustees Of The University Of Pennsylvania, The Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
GB9714971D0 (en) 1997-07-16 1997-09-24 Cancer Res Campaign Tech Assays,therapeutic methods and means
GB9718952D0 (en) * 1997-09-05 1997-11-12 Medical Res Council Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods
CA2216559A1 (fr) * 1997-09-25 1999-03-25 Michel Roberge Inhibiteurs du point de controle g2 et dosage
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6071691A (en) * 1998-04-27 2000-06-06 Oregon Health Science University Materials and methods for modulating differentiation
US6387640B1 (en) 1999-02-10 2002-05-14 St. Jude Children's Research Hospital ATM kinase modulation for screening and therapies
US6348311B1 (en) 1999-02-10 2002-02-19 St. Jude Childre's Research Hospital ATM kinase modulation for screening and therapies
US6670167B1 (en) 1999-11-01 2003-12-30 Agouron Pharmaceuticals, Inc. Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
AU2003286729A1 (en) * 2002-10-25 2004-05-13 University Of Massachusetts Modulation of cellular proliferation
AU2004265149A1 (en) 2003-08-13 2005-02-24 Kudos Pharmaceuticals Limited Aminopyrones and their use as ATM inhibitors
CN101061111A (zh) 2004-09-20 2007-10-24 库多斯药物有限公司 Dna－pk抑制剂
TW200638938A (en) 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR053358A1 (es) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009433A1 (fr) * 1995-09-06 1997-03-13 Icos Corporation Genes de point de controle a cycle cellulaire

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009433A1 (fr) * 1995-09-06 1997-03-13 Icos Corporation Genes de point de controle a cycle cellulaire

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BENTLEY, N.J. ET AL.: "The Schizosaccharomyces pombe rad3 checkpoint gene", EMBO JOURNAL, vol. 15, no. 23, 1996, pages 6641 - 6651, XP002023634 *
CIMPRICH, K.A. ET AL.: "cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 93, April 1996 (1996-04-01), pages 2850 - 2855, XP002023632 *
HOEKSTRA, M.F.: "Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family", CURRENT OPINION GENET. DEV., vol. 7, no. 2, 1997, pages 170 - 175, XP002036687 *
SAVITSKY, K. ET AL.: "A single ataxia telangiectasia gene with a product similar to PI-3 kinase", SCIENCE, vol. 268, 23 June 1995 (1995-06-23), pages 1749 - 1753, XP002036686 *
SEATON, B.L. ET AL.: "Isolation and characterization of the Schizosaccharomyces pombe rad3 gene, involved in the DNA damage and DNA synthesis checkpoints", GENE, vol. 119, 1992, pages 83 - 89, XP002023633 *

Also Published As

Publication number Publication date
WO1997018323A2 (fr) 1997-05-22
AU1461197A (en) 1997-06-05
CN1199420A (zh) 1998-11-18
IL121306A0 (en) 1998-01-04
NO973279L (no) 1997-09-16
PL322876A1 (en) 1998-03-02
NO973279D0 (no) 1997-07-15

Similar Documents

Publication Publication Date Title
WO1997018323A3 (fr) Materiaux de kinase relatifs a la phosphatidylinositol kinase du point de controle du cycle cellulaire, et procedes
US6114148C1 (en) High level expression of proteins
WO1998012328A3 (fr) Polypeptides de bad humaine codant des acides nucleiques et leurs procedes d'utilisation
AU8719291A (en) Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE471373T1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
EP1102988B8 (fr) Procede d'evaluation de l'activite de la reponse immunitaire du sang et trousse d'essai correspondante
AU7177896A (en) Multidrug resistance gene
MXPA98003564A (es) Genes de des-epoxidasa de violaxantina de planta ysus metodos relacionados.
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
CA2173102A1 (fr) Sequence d'adn codant pour un recepteur de la proteine morphogenetique osseuse
FI971896A7 (fi) BMP-tyyppi II-reseptoria koodaava cDNA
ATE205600T1 (de) Leukozytadhaesiontest
MX9705466A (es) Materiales y metodos de quinasa relacionada con fosfatidilinositolquinasa de punto de control del ciclo celular.
FI973005L (fi) Solusyklin kontrollikohdan PIK-sukuisia kinaasimateriaaleja ja menetelmiä
WO1995000554A3 (fr) Recepteurs de cellules souches hematopoietiques totipotentes et leurs ligands
AU4917300A (en) Method for producing a recombinant protein
WO1998024902A8 (fr) Proteine adaptatrice et produits et procedes associes
MX9606257A (es) Proteinas de sintasa de difosfato de geranilgeranilo, moleculas de acido nucleico, y usos de las mismas.
WO1999047709A3 (fr) Procede d'identification d'agents anticancereux
WO1999020761A3 (fr) Composition et procedes permettant d'identifier et de tester des agents therapeutiques contre l'infection a hsv
AU6667496A (en) A method and kit for evaluating the metastatic tendency of tumors
AU9437598A (en) Method and kit for identifying interactions between proteins or peptides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96192586.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

WWE Wipo information: entry into national phase

Ref document number: 973005

Country of ref document: FI

ENP Entry into the national phase

Ref document number: 2210650

Country of ref document: CA

Ref document number: 2210650

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1997/005466

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: PV1997-2547

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 111597

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1996945181

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

WWP Wipo information: published in national office

Ref document number: 1996945181

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1997-2547

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1996945181

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1997-2547

Country of ref document: CZ